Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Factors enhancing seizure freedom with perampanel monotherapy in neurosurgical ICU
TCTR20240429003Phase 3Completed
- Sponsor
- Phramongkutklao Hospital Foundation
- Start
- Jul 2020
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of perampanel in seizure disorder, sponsored by Phramongkutklao Hospital Foundation. Started Jul 2020; status: completed.
02
Drugs
perampanel
03
Conditions
seizure disorder
Beyond the preview
Go deeper on TCTR20240429003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240429003.